Document:

Exhibit 10.1

 

Execution Version

 

SUPPLEMENTAL SUPPORT AGREEMENT

 

SUPPLEMENTAL SUPPORT AGREEMENT, dated as of September 27, 2013 (this “Agreement”), by and among CNH Global N.V., a Netherlands corporation (“Global”), FI CBM Holdings N.V. (to be renamed CNH Industrial N.V. upon or after the effectiveness of the Merger referred to below), a Netherlands corporation (“Industrial”), and CNH Capital LLC, a Delaware limited liability company (“CNHC”).

 

W I T N E S S E T H :

 

WHEREAS, Global and CNHC are parties to that certain Support Agreement, dated as of November 4, 2011 (the “Support Agreement”);

 

WHEREAS, pursuant to the Merger Agreement, dated as of November 25, 2012 (the “Merger Agreement”), by and among Fiat Industrial S.p.A., Fiat Netherlands Holding N.V., Global and Industrial, Global shall merge with and into Industrial (the “Merger”) and, upon the consummation of the Merger, the separate corporate existence of Global shall cease and Industrial shall continue as the surviving corporation; and

 

WHEREAS, Industrial and CNHC believe that it is in their respective best interest for Industrial to expressly assume all of Global’s obligations under the Support Agreement so as to demonstrate Industrial’s support for CNHC following the Merger in connection with the matters contemplated by the Support Agreement;

 

NOW, THEREFORE, in consideration of the foregoing, the mutual advantage and benefit of the parties hereto and other good and valuable consideration, the parties hereto agree as follows:

 

1.                                      Defined Terms.  Capitalized terms used but not defined herein shall have the meanings assigned to them in the Support Agreement.

 

2.                                      Assumption of Obligations; Successor Substituted.  Industrial hereby expressly assumes, confirms and agrees to perform and observe, effective as of the CNH Effective Time (as defined in the Merger Agreement), all of the obligations, covenants, agreements, terms, conditions, duties and liabilities of Global under the Support Agreement, with the same force and effect as if Industrial had originally been a party thereto. Industrial shall, from and after the CNH Effective Time, succeed to, and be substituted for, and may exercise every right and power of, Global under the Support Agreement.

 

3.                                      General.

 

(a)                                 Confirmation.  Except as expressly supplemented hereby, the provisions of the Support Agreement shall remain in full force and effect.

 

 

(b)                                 Governing Law.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York.

 

(c)                                  Successors and Assigns. This Agreement shall be binding upon, and shall inure to the benefit of, Industrial and CNHC and their respective successors and assigns.

 

(d)                                 Counterparts.  The parties hereto may sign multiple counterparts of this Agreement. Each signed counterpart shall be deemed an original, but all of them together represent one and the same instrument.

 

2

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.

 

 

	
 
    	
CNH   GLOBAL N.V.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Andrea Paulis
    
	
 
    	
Name:
    	
Andrea   Paulis
    
	
 
    	
Title:
    	
Treasurer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
FI CBM Holdings N.V.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Roberto Russo
    
	
 
    	
Name:   
    	
Roberto   Russo
    
	
 
    	
Title:
    	
Corporate   Secretary
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
CNH   Capital LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Douglas MacLeod
    
	
 
    	
Name:   
    	
Douglas   MacLeod
    
	
 
    	
Title:
    	
Chief   Financial Officer
    

 

[Supplemental Support Agreement]Exhibit
4.1

 

	
  

  	
  INCORPORATED
  UNDER THE LAWS OF THE STATE OF DELAWARE INCORPORATED UNDER THE LAWS OF THE
  STATE OF DELAWARE COMMON STOCK FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON
  STOCK, $0.0001 PAR VALUE, OF TETRALOGIC PHARMACEUTICALS CORPORATION transferable
  on the books of the Corporation by the holder hereof in person or by Attorney
  upon surrender of this certificate properly endorsed. This certificate is not
  valid until countersigned and registered by the Transfer Agent and Registrar.
  IN WITNESS WHEREOF, the said Corporation has caused this certificate to be
  signed by facsimile signatures  of its
  duly authorized officers Dated: PRESIDENT AND CHIEF EXECUTIVE OFFICER CHIEF
  FINANCIAL OFFICER AND SECRETARY

  

 

	
  

  	
  The following
  abbreviations, when used in the inscription on the face of this certificate,
  shall be construed as though they were written out in full according to
  applicable laws or regulations: TEN COM – as tenants in common UNIF GIFT MIN
  ACT -  Custodian  under TEN ENT – as tenants by the entireties  (Cust) (Minor) JT TEN – as joint tenants
  with right of survivorship Uniform Gifts to Minors Act and not as tenants in
  common  (State) Additional
  abbreviations may also be used though not in the above list. For Value
  Received,  hereby sell, assign and transfer
  unto PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE
  (PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING ZIP CODE OF ASSIGNEE)
  Shares of the capital stock represented by the within Certificate, and do
  hereby irrevocably constitute and appoint 
  Attorney to transfer the said stock on the books of the within-named
  Corporation with full power of substitution in the premises. Dated X  XExhibit 4.17

 

AMENDMENT NO. 1 TO 
 WARRANT TO PURCHASE EQUITY SECURITIES
 OF TETRALOGIC PHARMACEUTICALS CORPORATION

 

THIS AMENDMENT NO. 1 (this “Amendment”), effective as of the          day of October 2013, by and between TETRALOGIC PHARMACEUTICALS CORPORATION, a Delaware corporation (the “Company”), and [WARRANT HOLDER] (the “Holder”), amends certain warrants issued to Holder pursuant to that certain Note and Warrant Purchase Agreement dated                                     by and among the Company and the Purchasers (as defined therein) and that certain Note and Warrant Purchase Agreement dated                                     by and among the Company and the Purchasers (as defined therein) (each of the warrants issued under such purchase agreements are referred to as a “Warrant” and collectively, the “Warrants”).  All capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrants.

 

WHEREAS, the Holder and the Company desire to amend the Warrants.

 

NOW, THEREFORE, the Company and the Holder, for good and valuable consideration, the receipt and sufficiency of which is acknowledged, intending to be legally bound, hereby agree as follows:

 

1.                                      AMENDMENTS.

 

1.1.                            Section 1(a) of each Warrant is hereby replaced in its entirety with the following:

 

“(a)                           “Equity Securities” shall mean (i) in the event of an initial public offering of securities of the Company under the Act (an “IPO”), the Company’s Series C Preferred Stock, (ii) to the extent that the Notes issued under the Purchase Agreement have converted in connection with a Qualified Financing or a Non-Qualified Financing (each as defined in the Notes) prior to twelve months after the issuance date hereof (the “Trigger Date”), other than a financing that is an IPO, then the equity securities issued by the Company in such financing, (iii) to the extent that the Notes issued under the Purchase Agreement have not converted in connection with a Qualified Financing or a Non-Qualified Financing prior to the Trigger Date and in the absence of an IPO, then at the election of the Holder, either (a) the Company’s Series C Preferred Stock or (b) the series of preferred stock issued by the Company in the first preferred stock financing completed by the Company after the Trigger Date, and (iv) in the event of a Liquidation (as defined in the Company’s Certificate of Incorporation, as amended to date) prior to the determination of the Equity Securities pursuant to (i), (ii) or (iii) above, then at the election of the Holder either (a) the Company’s Series C Preferred Stock or (b) the equity securities issued in any Non-Qualified Financing.”

 

1.2.                            Section 1(c) of each Warrant is hereby replaced in its entirety with the following:

 

“(c)                            “Exercise Price” shall mean the price per share for the equity securities that the comprise the Exercise Shares, subject to adjustment pursuant to Sections 5 and 8 below.

 

2.                                      NO FURTHER MODIFICATIONS.  Each provision of the Warrants not expressly amended or restated in this Amendment No. 1 shall remain unmodified and in full force and effect unless and until terminated in accordance with the terms thereof.

 

3.                                      MISCELLANEOUS.

 

3.1.                            Entire Agreement.  Each Warrant, as modified by this Amendment, and the Note and Warrant Purchase Agreement referred to in the preamble to this Amendment constitutes the entire agreement of the Company and the Holder with respect to the subject matter of such Warrant and supersedes all other discussions, negotiations and understandings with respect to such subject matter.  Any reference to each Warrant from and after the date of this Amendment shall be deemed and construed as meaning such Warrant as modified by this Amendment.

 

3.2.                            Ratification.  Except as expressly waived, amended, modified or supplemented hereby, the Warrant and the respective rights and obligations of each party thereto which are provided therein are hereby ratified and confirmed and shall continue in full force and effect.

 

3.3.                            Counterparts.  This Amendment may be executed in multiple counterparts, whether by facsimile or otherwise, none of which need contain the signatures of all parties, each of which shall be deemed to be an original, and all of which taken together shall constitute one and the same instrument.

 

[Signatures on Following Page.]

 

 

IN WITNESS WHEREOF, the parties hereby intending to be legally bound, have cause this Amendment No. 1 to Warrants to Purchase Equity Securities to be executed by their duly authorized representatives.

 

 

	
HOLDER:
    	
 
    	
COMPANY:
    
	
 
    	
 
    	
 
    
	
[WARRANT HOLDER]
    	
 
    	
TETRALOGIC   PHARMACEUTICALS CORPORATION
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
By
    	
 
    	
 
    	
By
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
Print   Name
    	
 
    	
 
    	
Print   Name
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
Title
    	
 
    	
 
    	
Title
    	
 
    
	
duly   authorized
    	
 
    	
duly   authorized

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00223-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00223-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00223-of-00352.parquet"}]]